4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-063035
Director sold 3,000 shares at an average $71.26 ($213,780)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waddill William D. Director | 2020-12-10 | Sale | −1,200 | $68.50 | $82,200 | 26,800 | D |
| Waddill William D. Director | 2020-12-10 | Sale | −1,800 | $73.10 | $131,580 | 25,000 | D |
| Open-market sales · 3,000 sh · avg $71.26 · $213,780 | |||||||
Loading xslF345X03/doc4.xml…